David Happel - 21 Jul 2025 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
President & CEO, Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Issuer symbol
SGMT
Transactions as of
21 Jul 2025
Net transactions value
-$598,115
Form type
4
Filing time
23 Jul 2025, 16:16:25 UTC
Previous filing
07 Feb 2025
Next filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Happel David President & CEO, Director SAGIMET BIOSCIENCES INC., 155 BOVET RD., SUITE 303, SAN MATEO /s/ Elizabeth Rozek, Attorney-in-Fact 23 Jul 2025 0001623567

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Sale $598,115 -65,478 -8.7% $9.13 689,722 21 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.